Table 1.

Expression of USP8 and HER-2 and Patient Characteristics

Characteristic	No.	USP8		P value	HER-3		P value
		High Expression	Low Expression		High Expression	Low Expression
Gender				0.862			0.520
Male	75	19	56		24	51
Female	13	3	10		3	10
Age (yr)				0.218			0.682
<60	42	8	34		12	30
≥60	46	14	32		15	31
Tumor size (cm)				0.177			0.991
<3	27	4	22		8	18
≥3	61	18	44		19	34
Location				0.805			0.958
AEG	46	11	35		14	32
Others	42	11	31		13	29
Differentiation				0.665			0.810
Well/Moderate	21	6	15		6	15
Poor	67	16	51		21	46
Lauren type				0.771			0.464
Intestinal	41	11	30		11	30
Diffuse	47	11	36		16	31
Nerve invasion				0.065			0.016
Yes	45	15	30		19	26
No	43	7	36		8	35
Vascular tumor emboli				0.268			0.078
Yes	43	13	30		17	26
No	45	9	36		10	35
T stage				0.295			0.112
T1+T2	19	3	16		3	16
T3+T4	69	19	50		24	45
N stage				0.006			0.001
N0	29	2	27		2	27
N13	59	20	39		25	34
pTNM stage				0.004			0.021
I+II	39	4	35		7	32
III	49	18	31		20	29

Note: P values were calculated by the chi-square test.

Abbreviations: AEG, adenocarcinomas of the esophagogastric junction; T, tumor; N, node; pTNM, pathological tumour node metastases.